Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$83.4K Hold
237
0.05% 84
2025
Q4
$77.6K Hold
237
0.05% 85
2025
Q3
$66.9K Hold
237
0.04% 85
2025
Q2
$66.2K Hold
237
0.05% 79
2025
Q1
$73.8K Hold
237
0.05% 82
2024
Q4
$61.8K Hold
237
0.04% 83
2024
Q3
$76.4K Hold
237
0.05% 77
2024
Q2
$74.1K Hold
237
0.06% 69
2024
Q1
$67.4K Hold
237
0.05% 77
2023
Q4
$68.3K Hold
237
0.06% 74
2023
Q3
$63.7K Buy
+237
New +$59.1K 0.05% 82

Other funds holding AMGN

Syntax Research's AMGN Position: Q1 2026 in Review

Syntax Research held its Amgen (AMGN) position steady in Q1 2026 at 237 shares worth $83.4K. The position accounts for 0.05% of the portfolio, ranked #84.

Syntax Research first reported a position in AMGN in Q3 2023 and has held it in 11 quarters since. 3,129 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Syntax Research held 237 shares of Amgen worth $83.4K as of Q1 2026.
  • Syntax Research left its Amgen share count unchanged in Q1 2026.
  • Amgen made up 0.05% of Syntax Research's portfolio in Q1 2026, its #84 holding.
  • Syntax Research first reported a position in Amgen in Q3 2023 and has held it in 11 quarters since.
  • 3,129 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Syntax Research's 13F filing for Q1 2026, filed 24 Apr 2026.